Magma Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
- Paid Up Capital ₹ 6.44 M
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 13.13%
- Profit Growth 97.65%
- Ebitda 154.47%
- Net Worth -0.08%
- Total Assets -3.11%
About Magma Lifesciences
Magma Lifesciences Private Limited (MLPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 December 2010 and has a history of 14 years and one month. Its registered office is in Thrissur, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 6.44 M, as per Ministry of Corporate Affairs (MCA) records.
Tony Joseph and Leena Tony serve as directors at the Company.
Company Details
- Location
Thrissur, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397KL2010PTC027318
- Company No.
027318
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Magma Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tony Joseph  | Managing Director | 20-Jun-2017 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Leena Tony | Director | 20-Jun-2017 | Current |
Financial Performance of Magma Lifesciences.
Magma Lifesciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 13.13% increase. The company also saw a substantial improvement in profitability, with a 97.65% increase in profit. The company's net worth dipped by a decrease of 0.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Magma Lifesciences?
In 2020, Magma Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Arikkatt Kuries Private LimitedTony Joseph is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Magma Lifesciences?
Magma Lifesciences has a workforce of 12 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Magma Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magma Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
